carbamates has been researched along with Fibrosis in 12 studies
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Accordingly, we evaluated the efficacy of 8 weeks fixed-dose combination of grazoprevir-elbasvir in treatment-naïve patients, with non-severe fibrosis." | 9.34 | Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis. ( Abergel, A; Andant, N; Asselah, T; Bailly, F; Buchard, B; Chanteranne, B; Di Martino, V; Dodel, M; Faure, F; Fouchard-Hubert, I; Gournay, J; Lamblin, G; Larrey, D; Loustaud-Ratti, V; Mallat, A; Muti, L; Pereira, B; Pol, S; Reymond, M; Samuel, D; Teilhet, C; Tran, A, 2020) |
| " Accordingly, we evaluated the efficacy of 8 weeks fixed-dose combination of grazoprevir-elbasvir in treatment-naïve patients, with non-severe fibrosis." | 5.34 | Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis. ( Abergel, A; Andant, N; Asselah, T; Bailly, F; Buchard, B; Chanteranne, B; Di Martino, V; Dodel, M; Faure, F; Fouchard-Hubert, I; Gournay, J; Lamblin, G; Larrey, D; Loustaud-Ratti, V; Mallat, A; Muti, L; Pereira, B; Pol, S; Reymond, M; Samuel, D; Teilhet, C; Tran, A, 2020) |
| "Using data from a phase III clinical trial (GIFT-I) that enrolled Japanese patients with HCV genotype 1b infection, population pharmacokinetic models were developed for the drugs that comprise the 2D regimen: paritaprevir, ombitasvir, and ritonavir." | 2.84 | Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection. ( Gopalakrishnan, SM; Khatri, A; Menon, RM; Mensing, S; Polepally, AR, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, H | 2 |
| Li, Z | 1 |
| Li, T | 2 |
| Wu, H | 1 |
| Yang, J | 2 |
| Yang, X | 2 |
| Yang, Y | 2 |
| Jiang, N | 1 |
| Zhai, X | 2 |
| Cao, Z | 1 |
| Liu, Z | 1 |
| Sun, R | 1 |
| Mashaal, AR | 1 |
| Abd El-Hameed, M | 1 |
| El Ray, AA | 1 |
| Mahmoud Diab, T | 1 |
| Dawood, RM | 1 |
| Shemis, MA | 1 |
| Seyam, M | 1 |
| Kim, JW | 1 |
| Abergel, A | 1 |
| Asselah, T | 1 |
| Mallat, A | 1 |
| Chanteranne, B | 1 |
| Faure, F | 1 |
| Larrey, D | 1 |
| Gournay, J | 1 |
| Loustaud-Ratti, V | 1 |
| Di Martino, V | 1 |
| Fouchard-Hubert, I | 1 |
| Pol, S | 1 |
| Bailly, F | 1 |
| Samuel, D | 1 |
| Tran, A | 1 |
| Dodel, M | 1 |
| Andant, N | 1 |
| Lamblin, G | 1 |
| Muti, L | 1 |
| Reymond, M | 1 |
| Teilhet, C | 1 |
| Pereira, B | 1 |
| Buchard, B | 1 |
| Milan, M | 1 |
| Pace, V | 1 |
| Maiullari, F | 1 |
| Chirivì, M | 1 |
| Baci, D | 1 |
| Maiullari, S | 1 |
| Madaro, L | 1 |
| Maccari, S | 1 |
| Stati, T | 1 |
| Marano, G | 1 |
| Frati, G | 1 |
| Puri, PL | 2 |
| De Falco, E | 1 |
| Bearzi, C | 1 |
| Rizzi, R | 1 |
| Consalvi, S | 1 |
| Mozzetta, C | 1 |
| Bettica, P | 1 |
| Germani, M | 1 |
| Fiorentini, F | 1 |
| Del Bene, F | 1 |
| Rocchetti, M | 1 |
| Leoni, F | 1 |
| Monzani, V | 1 |
| Mascagni, P | 1 |
| Saccone, V | 1 |
| Beinhardt, S | 1 |
| Peck-Radosavljevic, M | 1 |
| Hofer, H | 1 |
| Ferenci, P | 1 |
| Saab, S | 1 |
| Parisé, H | 1 |
| Virabhak, S | 1 |
| Wang, A | 1 |
| Marx, SE | 1 |
| Sanchez Gonzalez, Y | 1 |
| Misurski, D | 1 |
| Johnson, S | 1 |
| Gopalakrishnan, SM | 1 |
| Polepally, AR | 1 |
| Mensing, S | 1 |
| Khatri, A | 1 |
| Menon, RM | 1 |
| Gross, ML | 1 |
| Piecha, G | 1 |
| Bierhaus, A | 1 |
| Hanke, W | 1 |
| Henle, T | 1 |
| Schirmacher, P | 1 |
| Ritz, E | 1 |
| Wang, J | 1 |
| Kulkarni, A | 1 |
| Chintala, M | 1 |
| Fink, LM | 1 |
| Hauer-Jensen, M | 1 |
1 review available for carbamates and Fibrosis
| Article | Year |
|---|---|
Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cholestasis, Intrahepatic; Clinical Trials | 2015 |
2 trials available for carbamates and Fibrosis
| Article | Year |
|---|---|
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
Topics: Adult; Aged; Amides; Antiviral Agents; Asia; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, C | 2020 |
Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.
Topics: Adolescent; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Double-Blind Method; | 2017 |
9 other studies available for carbamates and Fibrosis
| Article | Year |
|---|---|
Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model.
Topics: Animals; Carbamates; Disease Models, Animal; Fibrosis; Lung; Mice; Phosphoric Diester Hydrolases; Pi | 2022 |
Hybrid imidazo[1,2-a]pyridine analogs as potent ATX inhibitors with concrete in vivo antifibrosis effect.
Topics: Bleomycin; Carbamates; Fibrosis; Humans; Phosphoric Diester Hydrolases; Pyridines; Structure-Activit | 2022 |
Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
Topics: Aged; alpha-Fetoproteins; Antiviral Agents; Carbamates; Cross-Sectional Studies; Drug Therapy, Combi | 2022 |
What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
Topics: Antiviral Agents; Carbamates; Fibrosis; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazo | 2019 |
Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation.
Topics: Animals; Apoptosis; Carbamates; Endothelium; Epithelium; Female; Fibroblasts; Fibrosis; Gene Express | 2018 |
Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat.
Topics: Animals; Carbamates; Cells, Cultured; Exercise Test; Fibrosis; Histone Deacetylase Inhibitors; Human | 2013 |
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbama | 2016 |
Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney.
Topics: Albumins; Ambystoma mexicanum; Animals; Carbamates; Fibrosis; Glycated Serum Albumin; Glycation End | 2011 |
Inhibition of protease-activated receptor 1 ameliorates intestinal radiation mucositis in a preclinical rat model.
Topics: Animals; Benzofurans; Carbamates; Fibrosis; Intestinal Mucosa; Intestine, Small; Male; Mucositis; Pe | 2013 |